Patterns in adolescent cannabis use predict the onset and symptom structure of schizophrenia-spectrum disorder.

Autor: Shahzade C; Laboratory for Clinical & Experimental Psychopathology, Beth Israel Deaconess Medical Center, 49 Hillside St., Fall River, MA 02720, United States., Chun J; Laboratory for Clinical & Experimental Psychopathology, Beth Israel Deaconess Medical Center, 49 Hillside St., Fall River, MA 02720, United States; Harvard Commonwealth Research Center of Excellence in Clinical Neuroscience and Psychopharmacological Research, Fall River, MA 02720, United States., DeLisi LE; Department of Psychiatry, Harvard Medical School, VA Boston Healthcare System, 940 Belmont St., Brockton, MA 02301, United States., Manschreck TC; Laboratory for Clinical & Experimental Psychopathology, Beth Israel Deaconess Medical Center, 49 Hillside St., Fall River, MA 02720, United States; Harvard Commonwealth Research Center of Excellence in Clinical Neuroscience and Psychopharmacological Research, Fall River, MA 02720, United States; Department of Psychiatry, Harvard Medical School, VA Boston Healthcare System, 940 Belmont St., Brockton, MA 02301, United States. Electronic address: Theo.Manschreck@MassMail.state.ma.us.
Jazyk: angličtina
Zdroj: Schizophrenia research [Schizophr Res] 2018 Jul; Vol. 197, pp. 539-543. Date of Electronic Publication: 2018 May 07.
DOI: 10.1016/j.schres.2018.01.008
Abstrakt: This study investigated adolescent cannabis use as a risk factor for schizophrenia spectrum disorder (SSD). Motives for early cannabis use and resulting usage patterns were examined alongside clinical measures of SSD onset and symptomatology. Participants (N = 178) were recruited for two samples, 1: healthy controls (HC) with cannabis use, 2: schizophrenia patients (SSD) with cannabis use. Structured interviews of participants and family informants were used to obtain diagnostic and biographical information. Factor-analysis of reported motives for initiating cannabis use produced four groups; sedation, stimulation, social pressure, and recreation. Regression analyses revealed significant relationships between these groups and SSD. Most notably, reason group factor scores predict SSD risk as well as schizotypal symptom severity. Findings also indicate that these factors follow a hierarchical structure, which explains their relative involvement in increased SSD risk. We suggest that adolescent cannabis use both hastens the onset and amplifies the severity of SSD. In response we propose a model for identifying at risk individuals, predicting the onset and severity of SSD, and potentially mitigating the associated psychiatric impairments.
(Copyright © 2018. Published by Elsevier B.V.)
Databáze: MEDLINE
Externí odkaz: